ATLASCentury Therapeutics (IPSC) earnings date: Nov 12, 2026
Century Therapeutics (IPSC) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026, before the open. Analysts expect EPS of -$0.12.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on IPSC
| Last price | $1.47 (+0.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.8% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Century Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Century Therapeutics reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Century Therapeutics. You can switch it off at any time.
Alert me before IPSC reportsFree to start. Creating an account takes under a minute.
IPSC earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.12 |
| Last report | Aug 12, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +14.3% |
| Average move around a report | ±9.5% (last 5) |
| Sector | Healthcare · Biotechnology |
Century Therapeutics earnings history: last 5 reports
Century Therapeutics last reported on Aug 12, 2026: EPS of -$0.11 against an estimate of -$0.12 (+8.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.12 | -$0.11 | +8.3% | Beat | -6.3% |
| May 13, 2026 | -$0.17 | -$0.11 | +35.3% | Beat | +3.9% |
| Mar 12, 2026 | -$0.30 | -$0.25 | +16.7% | Beat | -14.3% |
| Nov 13, 2025 | -$0.38 | -$0.32 | +15.8% | Beat | -16.2% |
| Nov 4, 2025 | $3.16 | $3.01 | -4.7% | Miss | -6.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for IPSC
See the fair value, the probability range and the earnings history of Century Therapeutics on its ATLAS page.
Century Therapeutics (IPSC) stock analysisPlans from €3.99 a month.
Century Therapeutics earnings: frequently asked questions
When does Century Therapeutics (IPSC) report earnings?
Century Therapeutics is scheduled to report on Thursday, November 12, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for IPSC?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.12 per share (USD). Estimates can change before the report.
How often does IPSC beat earnings estimates?
Of its last 5 reports with a recorded result, Century Therapeutics beat the EPS estimate 4 times; the average surprise was +14.3%. Past results do not predict the next one.
How much does IPSC move around earnings?
Over its last 5 reports the stock moved an average of 9.5% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Century Therapeutics beat earnings estimates last quarter?
Century Therapeutics last reported on Aug 12, 2026: EPS of -$0.11 against an estimate of -$0.12 (+8.3% surprise), a beat.
How much does IPSC usually move in a day?
On a normal trading day the ATLAS model puts IPSC’s one-day range at about ±4.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer